MedTrace Logo

Hepatitis C Among Opioid Addicts in Opioid Maintenance Treatment in Zurich, Switzerland

NCT00473993 · Status: COMPLETED · Type: OBSERVATIONAL

Last updated 2009-02-16

No results posted yet for this study

Summary

Hepatitis C viral infection is common among opioid addicts in Zurich, Switzerland. The majority undergoes a maintenance treatment with methadone, heroin or buprenorphine. While stabilized by an opioid maintenance treatment (OMT)chronic hepatitis C can be treated with pegylated interferon plus ribavirin. As not sufficiently known, the results are comparable to the results of the treatment of nonaddicts.

Our crossectional study investigates how many patients undergoing OMT are adequately investigated concerning hepatitis C. If not, why are they not adequately investigated and treated? Representative data are collected in the local clinics and medical practices involved in OMT in the Kanton of Zurich. The patients files are revised and the involved doctors are asked through a structured interview.

Conditions

  • Hepatitis C, Chronic
  • Substance Abuse Treatment Centers
  • Opioid-Related Disorders

Sponsors & Collaborators

  • University of Zurich

    collaborator OTHER

  • Seidenberg, Arztpraxis A., M.D.

    lead INDIV

Principal Investigators

  • André Seidenberg, Dr.med. · research fellow EHAM, University of Zurich

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-07-31
Completion
2007-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00473993 on ClinicalTrials.gov